Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antiviral agents directed against respiratory syncytial virus

Antiviral agents directed against respiratory syncytial virus

US Patent 10213413 · Granted Feb 26, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Azobenzene derivatives, process for their preparation and their use for therapeu2025
Anti-dengue vaccines and antibodies2025
Anti-dengue vaccines and antibodies2025
Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A diseas2024
Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A diseas2024
Neutralising antibody against dengue for use in a method of prevention and/or tr2024
Stabilized recombinant hantaviral spike proteins comprising mutations in Gc2023
Bioconjugates of neuropeptides derivatives2023
Anti-dengue vaccines and antibodies2021
Anti-dengue vaccines and antibodies2021
Neutralising antibody against dengue for use in a method of prevention and/or tr2021
Respiratory syncytial virus (RSV) replication inhibitors2020